Resources

Media Coverage

Curating Biological Findings from Scientific Literature with NVIDIA NIM

Media Coverage

How top pharma companies boost efficacy

Scientific Publications

June 12th, 2024

Interactions between immune cell types facilitate the evolution of immune traits

Media Coverage

Digital Health 50: The most promising digital health startups of 2024

Press Release

July 17th, 2024

CytoReason Secures $80M from OurCrowd, NVIDIA, Pfizer, and Thermo Fisher Scientific to Scale Its AI Disease Models and Establish US Hub in Cambridge, Massachusetts

Blog

May 21st, 2024

Revolutionizing IBD Treatment: The CytoReason and CCF Partnership

Press Release

May 15th, 2024

CytoReason and the Crohn’s & Colitis Foundation Forge Groundbreaking Data Collaboration to Advance IBD Research

Press Release

October 27th, 2023

Reconstructing disease dynamics for mechanistic insights and clinical benefit

Blog

August 22nd, 2023

Navigating Drug Development: CytoReason’s Disease Model Platform

Find out more about the Disease Model Platform by watching our new video

Bring your data to life